Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M T, Melucci"'
Autor:
P.A. Ascierto, M. T. Melucci, Antonio Daponte, R. A. Satriano, Giuseppe Palmieri, Giuseppe Castello, Nicola Mozzillo
Publikováno v:
Melanoma research 12 (2002): 293–296. doi:10.1097/00008390-200206000-00015
info:cnr-pdr/source/autori:Ascierto, P. A.; Palmieri, G.; Daponte, A.; Melucci, M. T.; Satriano, R. A.; Mozzillo, N.; Castello, G./titolo:Adjuvant therapy of melanoma: What's new?/doi:10.1097%2F00008390-200206000-00015/rivista:Melanoma research/anno:2002/pagina_da:293/pagina_a:296/intervallo_pagine:293–296/volume:12
info:cnr-pdr/source/autori:Ascierto, P. A.; Palmieri, G.; Daponte, A.; Melucci, M. T.; Satriano, R. A.; Mozzillo, N.; Castello, G./titolo:Adjuvant therapy of melanoma: What's new?/doi:10.1097%2F00008390-200206000-00015/rivista:Melanoma research/anno:2002/pagina_da:293/pagina_a:296/intervallo_pagine:293–296/volume:12
Adjuvant therapy of melanoma
Autor:
Nicola Mozzillo, Francesco Perrone, Paolo A. Ascierto, Corrado Caracò, M. T. Melucci, Maria Napolitano, Rosanna Parasole, Giuseppe Castello, Giuseppe Palmieri, Antonio Daponte
Publikováno v:
Cancer. 89:1490-1494
BACKGROUND Interferon (IFN) is widely considered the most effective agent in the adjuvant therapy of patients with cutaneous melanoma (CM). However, little is known about the effect of IFN on pretreated CM patients who experience disease recurrence.
Autor:
Corrado Caracò, Paolo A. Ascierto, Maria Grazia Chiofalo, Giuseppe Palmieri, Giuseppe Castello, Nicola Mozzillo, Egidio Celentano, Rosanna Parasole, Antonio Daponte, R. A. Satriano, M. T. Melucci
Publikováno v:
British Journal of Dermatology. 142:893-898
To evaluate the role of epiluminescence microscopy (ELM) in the differential diagnosis of cutaneous pigmented lesions, and to improve the early diagnosis of cutaneous malignant melanoma (CMM), 15,719 pigmented lesions from 8782 consecutive patients w
Autor:
A, Daponte, P A, Ascierto, A, Gravina, M T, Melucci, G, Palmieri, P, Comella, R, Cellerino, M, DeLena, G, Marini, G, Comella
Publikováno v:
Cancer. 89(12)
In a previous study, the authors tested the combination of fotemustine (FM) 100 mg/m(2) intravenously (i.v.) on Day 1, dacarbazine (DTIC) 250 mg/m(2) i.v. on Days 2-5, and interferon alpha (IFNalpha) 3 MIU intramuscularly three times per week in 43 p
Autor:
P A, Ascierto, G, Palmieri, E, Celentano, R, Parasole, C, Caracò, A, Daponte, M G, Chiofalo, M T, Melucci, N, Mozzillo, R A, Satriano, G, Castello
Publikováno v:
The British journal of dermatology. 142(5)
To evaluate the role of epiluminescence microscopy (ELM) in the differential diagnosis of cutaneous pigmented lesions, and to improve the early diagnosis of cutaneous malignant melanoma (CMM), 15,719 pigmented lesions from 8782 consecutive patients w
Autor:
L Pezzullo, P.A. Ascierto, M. T. Melucci, Sergio Canzanella, Giuseppe Palmieri, Corrado Caracò, F. Ionna
Publikováno v:
Melanoma Research. 11:83-84